In particular, the butyrylated derivative GnRH-III-[4Lys(Bu),8Lys(Dau=Aoa)] (1) (Figure 1) displayed not only in vitro, but also in vivo an increased anti-tumor activity [25,34]. The gene discussed is GNRH1; the disease is neoplasm.